ROLE OF VEERAN-SHALI GRANULES ORALLY FOR LACTATION IN LACTATION DEFICIENT WOME
- Conditions
- Health Condition 1: O925- Suppressed lactation
- Registration Number
- CTRI/2021/09/036229
- Lead Sponsor
- niversity College Of AyurvedaJodhpur Rajsathan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Age group of patient is between 20-40 yrs.
2.Patients after delivery from 7th day to 6 months.
3.patients Baby of less than 6 month of age partly or totally on top feed.
4.Patients Baby weight more than or equal to 2.5 kg.
5.patient delivery should be at full term
1.Patient with congenital anomalies of breast (absence of nipple or the breast tissue).
2.Patient of breast atrophy and inverted nipple.
3.Patient with known case of immune compromised disease like AIDS, Cancer.
4.Patients having H/o alcoholism and smoking.
5.Patient of systemic disease like Diabetes mellitus.
6.Baby with congenital anomalies (cleft lip, cleft palate), birth trauma, premature birth.
7.Patient who is taking anti prolactin drug (bromocriptine, cabergoline) which suppress lactation.
8.Patient who is taking anti emetic drug (metaclopramide, domperidome) or antipsychotic drug (sulpiride) which increase lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate clinical efficacy of Veerana - Sali Granules in the management of StanyakshayaTimepoint: 60 days
- Secondary Outcome Measures
Name Time Method To evaluate clinical efficacy of Veerana - Sali Granules in the management of StanyakshayaTimepoint: 60 days <br/ ><br>Changes in the sign and symptoms will be recorded